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We describe treatment of atrial ﬂutter and electrical storm presenting as incessant ventricular
tachycardia (VT) after implantation of a cardiac resynchronization therapy deﬁbrillator (CRT-D) in a
patient with dilated cardiomyopathy. No prior arrhythmic event had occurred. Our treatment strategy,
including amiodarone administration, was guided in part by signal-averaged vector-projected 187-
channel electrocardiogram (SAVP-ECG)-based risk stratiﬁcation for ventricular arrhythmia. Corrected
recovery time (RTc) dispersion and Tpeak-end dispersion were used to evaluate transmural dispersion of
repolarization. RTc and Tpeak-end dispersion increased during the period of electrical storm. Values were
improved 2 years after CRT-D implantation, and the amiodarone was discontinued. The VT has not
recurred despite discontinuation of the antiarrhythmic agent. SAVP-ECG-based risk stratiﬁcation for
ventricular arrhythmia proved useful for the management of antiarrhythmic therapy.
& 2013 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Case report
A 77-year-old man with dilated cardiomyopathy visited our
hospital in December 2010 and reported dyspnea on effort. Echo-
cardiography revealed cardiac dyssynchrony with a low ejection
fraction of 29%, and the patient was diagnosed with New York Heart
Association class III heart failure. The plasma N-terminal pro-B-type
natriuretic peptide (NT-pro BNP) level was 3691 pg/mL. The elec-
trocardiogram (ECG) QRS complex (136 ms) was widened to
136 ms, with a left bundle branch block conturation (Fig. 1). The
patient was being treated with spironolactone (aldactone), β-
blocker (carvedilol), and angiotensin II receptor antagonist (capto-
pril). Implantation of a cardiac resynchronization therapy deﬁbril-
lator (CRT-D) was scheduled and performed in May 2011, without
any complications. After implantation of the right ventricular (RV)
lead in the RV apex, coronary venography was performed, and a
suitable lateral branch was identiﬁed as a candidate vessel for left
ventricular (LV) lead implantation. The LV lead was positioned at
the midportion of the lateral branch. The LV pacing threshold was
0.5 mV at 0.5 ms without phrenic nerve stimulation. The right atrialt Rhythm Society. Published by Els
; fax: +81 33972 1098.
kai).(RA) lead was then positioned at the RA appendage. The following
device and leads were used: Promote RF generator, Durata 7120Q
RV deﬁbrillation lead, QuickFlex 1158T LV lead, and Tendril STS RA
lead (St. Jude Medical, St. Paul, Minnesota, USA). The RV pacing
threshold was 0.75 V at 0.4 ms, and the RA pacing threshold was
0.5 V at 0.4 ms. The device was programmed with a ventricular
tachycardia (VT) zone set to ≥166 bpm (therapies¼antitachy pacing
(ATP)3, shock 10 J, 25 J, 36 J4) and a ventricular ﬁbrillation (VF)
zone set to ≥230 bpm (therapies¼shock 15 J, 36 J, 36 J4).
After CRT-D implantation, the QRS duration decreased to 122 ms
(Fig. 2), and the cardiac dyssynchrony improved. However, 5 days
after implantation, atrial ﬂutter (AFL) and electrical storm presenting
as frequent VT were seen. As shown in Fig. 3A, the VT was initiated
by a premature ventricular complex. The CRT-D intracardiac tracing
showed both AFL and VT. Appropriate shocks were delivered, and
both the AFL and VT were terminated (Fig. 3B); however, incessant
VT developed after restoration of sinus rhythm. A total of 9 VT zone
shocks were delivered. Biventricular pacing was discontinued, and
intravenous administration of amiodarone was initiated to inhibit
VT. The VT abated within 1 week, and CRT was restarted. Oral
amiodarone was administered to prevent VT recurrence. To deter-
mine the risk of ventricular arrhythmia, we evaluated the corrected
recovery time (RTc) dispersion and Tpeak-end dispersion on a
signal-averaged vector-projected 187-channel electrocardiogramevier B.V. All rights reserved.
Fig. 1. Twelve-lead electrocardiogram obtained before CRT shows a wide QRS complex with left bundle branch block.
Fig. 2. Twelve-lead electrocardiogram obtained after CRT shows narrowing of the QRS complex compared to that before CRT.
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period of electrical storm (average, 15 ms and 48 ms, respectively;
Fig. 4A). These ﬁndings suggest that transmural dispersion of
repolarization increased in our patient, leading to ventricular proar-
rhythmia. Two years after implantation of CRT-D, follow-up SAVP-
ECG showed decreased augmentation of RTc dispersion and Tpeak-
end dispersion (17 ms and 13 ms, respectively; Fig. 4B). It remains
unclear whether this improvement was the result of time or the
administration of amiodarone. We halved the dose of amiodarone
before withdrawing the drug altogether. No VT recurrence occurred
despite discontinuation of the antiarrhythmic agent.2. Discussion
Proarrhythmic events after CRT have been reported in 5–10% of
CRT recipients [1–4]. Gasparini et al. investigated the incidence of
electrical storm in patients with heart failure treated with CRT and
reported an increased incidence in patients with nonischemic
cardiomyopathy in whom a CRT-D was implanted for secondary
prevention [5]. In most cases, the arrhythmia can be managed byadministration of an antiarrhythmic agent and/or discontinuation
of LV pacing within 1 month after implantation of the CRT system.
Kantharia et al. reported a case of electrical storm induced by CRT.
The VT did not disappear even after extraction of the LV lead, and
catheter ablation was performed to control the VT [6]. In another
case, VT was induced by biventricular pacing and controlled by
triple-site biventricular pacing and atrioventricular node ablation [7].
In contrast, CRT has been reported to suppress arrhythmias in some
cases [8–10]. These reports suggest that the suppression is not
due to the effects of pacing itself. Rather, reverse remodeling with
CRT can decrease the AFL burden and frequency of ventricular
arrhythmias.
The mechanism underlying the proarrhythmic effect of CRT is not
well understood. One explanation is that transmural dispersion of
repolarization increases with LV pacing. Bai et al. studied the effects of
LV epicardial pacing and biventricular pacing in a canine model of
dilated cardiomyopathy [11] and showed that both LV epicardial
pacing and biventricular pacing prolonged the ventricular repolariza-
tion time and increased transmural dispersion of repolarization. Pro-
longed transmural dispersion occurred parallel to augmentation in the
Tpeak-end interval. According to Scott et al., CRT with transseptal
Fig. 3. Cardiac monitor tracing and intracardiac electrocardiogram shows atrial ﬁbrillation and ventricular tachycardia episodes 5 days after CRT-D implantation.
Fig. 4. RTc and Tpeak-end dispersion assessed on SAVP-ECG obtained 5 days and 1 year after CRT implantation. RTc and Tpeak-end dispersion were improved 2 years after
CRT implantation.
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duced QTc and Tpeak-end dispersion, and these authors concluded
that transseptal LV pacing may be less arrhythmogenic [12]. Barbhaiya
et al. looked at the relationship between ventricular arrhythmia, the
QT interval, and Tpeak-end dispersion and found that increases in
Tpeak-end dispersion and Tpeak-end/QT ratio were associated with an
increased incidence of ventricular arrhythmia in patients with a CRT-D
[13]. Another group also reported an association between Tpeak-end
dispersion and major arrhythmic events [14].
Nakai et al. showed that RTc and Tpeak-end dispersion can be
used to evaluate the spatial distribution of myocardial repolariza-
tion [15,16]. We measured RTc and Tpeak-end dispersion in the
acute and chronic periods in the case reported herein. Both
variables were increased during the acute period after CRT,
suggesting that repolarization heterogeneity was augmented
before being modiﬁed by amiodarone. These changes are consis-
tent with previous reports of prolongation of the Tpeak-end
interval with LV pacing. On the follow-up SAVP-ECG, RTc and
Tpeak-end dispersion had decreased to within safe ranges. There is
no standard index for use of antiarrhythmic agents, and it is
difﬁcult to make the decision to stop an antiarrhythmic agent once
it is started, even if the patient is free of arrhythmia. In the present
case, RTc/Tpeak-end dispersion increased in the acute phase after
CRT, suggesting a potential substrate for ventricular arrhythmia,
but both measures decreased to within normal range with
amiodarone administration and with time. We controlled the dose
of amiodarone in response to the low risk for ventricular arrhyth-
mia indicated by the SAVP-ECG. Our experience in this case
highlights the importance of risk stratiﬁcation for lethal arrhyth-
mia after CRT.3. Conclusion
We treated a patient who experienced electrical storm after
CRT-D implantation. Our treatment strategy was guided in part by
SAVP-ECG-based risk stratiﬁcation for ventricular arrhythmia. Our
SAVP-ECG ﬁndings indicate that the proarrhythmic effect of CRT
may be due to repolarization heterogeneity induced by LV pacing.
The SAVP-ECG ﬁndings allowed us to both administer and with-
draw the antiarrhythmic agent effectively; therefore, we suggest
use of SAVP-ECG as a risk stratiﬁcation tool in cases of CRT-
induced electrical storm.Conﬂict of interest
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